WebCurrently, intermediate to long SFA lesions (more complex occlusions) are treated by primary stenting. 7 Other adjunctive therapies such as atherectomy devices or cutting balloons may be used. If stenting is planned, nitinol self-expanding stents should be deployed because of external pressure in this region, which distorts the stents. Web(SFA) is the most common cause of intermittent claudication. Atherosclerotic disease of the SFA is localized to the region of Hunter’s canal. An isolated occlusion or stenosis of the …
Endovascular recanalization of chronic total occlusions of the …
WebDec 1, 2015 · First of all, the arteries treated differ among trials, as only two studies refer to infrapopliteal lesions and the rest of studies include patients with symptomatic lesions of the superficial or common femoral arteries. Secondly, some studies present only Future expectations and challenges WebPrimary patency rates were not different between Supera stents in the SFA and popliteal lesions. Brescia et al treated 48 patients with femoropopliteal lesions with a mean lesion length of... look up your criminal record
BioMimics 3D Stent in Femoropopliteal Lesions: 3-Year …
WebMar 31, 2024 · For lesion characteristics, the disease location was either flush ostial lesions in 10 (33.3%) or other SFA segment in 20 (66.7%). Most of patients, 17 (56.7%) were suffering from TASC (B) < 15 cm lesions, and 13 (43.3%) patients were suffering from TASC (A) < 10 cm lesions of SFA. WebThe average lesion length of 53±40 mm was treated using the Pantheris catheter alone or Pantheris + adjunctive therapy. Of the 198 target lesions, 104 (52.5%) were treated with the Pantheris alone, 84 (42.4%) with the Pantheris + adjunctive angioplasty, and ten (5.1%) with the Pantheris + angioplasty + stenting. WebLong SFA lesions Consider the demands of treating long-length lesions of the superficial femoral artery (SFA) Lesion length is a predictor of patency outcomes for several … look up your family history for free